What if it were possible to stave

off preventable mortality and convert the hope

of second chances

into a reality?

At XenoTherapeutics, our mission is to advance the science of xenotransplantation through education, research, development, and clinical testing towards a practical therapeutic use for the public benefit.

"In that moment of experiencing trauma, or a fatal diagnosis and then not knowing what the course of action is; finding a cure becomes the forefront of our minds. Even if we can stave off mortality for six months, a year, five years…what does that mean to the individual and their families? That is the goal of regenerative medicine and that is what we are delivering on.”

- Jon Adkins

President & CEO

XenoTherapeutics